- Home
- LSTA vs CRIS Comparison
LSTA vs CRIS Comparison
Compare LSTA & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- CRIS
- Stock Information
- Founded
- LSTA 1980
- CRIS 2000
- Country
- LSTA United States
- CRIS United States
- Employees
- LSTA N/A
- CRIS N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LSTA Health Care
- CRIS Health Care
- Exchange
- LSTA Nasdaq
- CRIS Nasdaq
- Market Cap
- LSTA 20.9M
- CRIS 22.9M
- IPO Year
- LSTA N/A
- CRIS 2000
- Fundamental
- Price
- LSTA $2.44
- CRIS $1.53
- Analyst Decision
- LSTA Strong Buy
- CRIS Strong Buy
- Analyst Count
- LSTA 2
- CRIS 2
- Target Price
- LSTA $23.50
- CRIS $16.50
- AVG Volume (30 Days)
- LSTA 43.5K
- CRIS 70.2K
- Earning Date
- LSTA 11-11-2025
- CRIS 11-13-2025
- Dividend Yield
- LSTA N/A
- CRIS N/A
- EPS Growth
- LSTA N/A
- CRIS N/A
- EPS
- LSTA N/A
- CRIS N/A
- Revenue
- LSTA $1,070,000.00
- CRIS $11,405,000.00
- Revenue This Year
- LSTA N/A
- CRIS $2.72
- Revenue Next Year
- LSTA N/A
- CRIS $8.27
- P/E Ratio
- LSTA N/A
- CRIS N/A
- Revenue Growth
- LSTA N/A
- CRIS 12.24
- 52 Week Low
- LSTA $1.87
- CRIS $1.02
- 52 Week High
- LSTA $4.20
- CRIS $5.45
- Technical
- Relative Strength Index (RSI)
- LSTA 49.36
- CRIS 41.47
- Support Level
- LSTA $2.35
- CRIS $1.44
- Resistance Level
- LSTA $2.61
- CRIS $1.63
- Average True Range (ATR)
- LSTA 0.16
- CRIS 0.10
- MACD
- LSTA -0.00
- CRIS -0.01
- Stochastic Oscillator
- LSTA 35.71
- CRIS 29.29
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.